DNLVX
Price
$21.35
Change
-$0.04 (-0.19%)
Updated
Sep 5 closing price
Net Assets
183.77M
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

DNLVX vs VIVIX

Header iconDNLVX vs VIVIX Comparison
Open Charts DNLVX vs VIVIXBanner chart's image
Dunham Large Cap Value N
Price$21.35
Change-$0.04 (-0.19%)
VolumeN/A
Net Assets183.77M
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
DNLVX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNLVX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLVX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. DNLVX (184M). VIVIX pays higher dividends than DNLVX: VIVIX (2.11) vs DNLVX (0.73). DNLVX was incepted earlier than VIVIX: DNLVX (21 years) vs VIVIX (27 years). DNLVX (1.19) is less costly to investors than VIVIX (0.04). DNLVX is a more actively managed with annual turnover of: 23.00 vs. VIVIX (9.00). DNLVX has a lower initial minimum investment than VIVIX: DNLVX (100000) vs VIVIX (5000000). DNLVX annual gain was more profitable for investors over the last year : 8.36 vs. VIVIX (7.74). VIVIX return over 5 years is better than : 70.16 vs. DNLVX (59.68).
DNLVXVIVIXDNLVX / VIVIX
Total Expense Ratio1.190.042,975%
Annual Report Gross Expense Ratio1.190.042,975%
Fund Existence21 years27 years-
Gain YTD11.0827.866141%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets184M203B0%
Annual Yield % from dividends0.732.1135%
Returns for 1 year8.367.74108%
Returns for 3 years32.2736.6188%
Returns for 5 years59.6870.1685%
Returns for 10 years50.15131.6138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia